DLHC

DLH Holdings Corp.

41
Fundamentals30/ 100
Valuation50/ 100
Upside potentialUnknown
Risk potentialUnknown

DLHC trails on the overall score without a compensating advantage in the available component scores.

VRT

Vertiv Holdings Co

87
Fundamentals85/ 100
Valuation87/ 100
Upside potential86/ 100
Risk potential19/ 100

VRT has the edge over DLHC overall, supported by stronger fundamentals and stronger valuation.

DLHC Fundamentals

MetricStatus
Weak
Under pressure
Stable
Weak

DLHC's cash flow is currently stable, but its revenue, profitability and balance sheet are under pressure.

VRT Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

VRT's revenue, profitability, cash flow and balance sheet are all currently strong.

DLHC PE Valuation

DLHC has no meaningful PE right now: it lost money over the past year.

VRT PE Valuation

CHEAPFAIREXPENSIVE39x77x116x155x
CHEAPFAIREXPENSIVE39x77x116x155x
LevelPEPriceVs current
Forward23x$210—
Current39x$210—
Cheap58x$308+47%
Fair72x$383+83%
Expensive88x$472+125%

Historical ranges are pointers, not guarantees.

VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.

DLHC Forward outlook

There aren't enough analyst estimates for DLHC to show an outlook.

VRT Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for VRT, with profitability improving.

DLHC Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $3.50 on Nov 12.

There is not enough scenario data to compare DLHC and VRT's risk to reward.

VRT Risk to reward

ScenarioChangePrice
Upside+122%$466.33
Downside-19%$169.11

Calculated from the latest close: $209.64 on Nov 12.

There is not enough scenario data to compare DLHC and VRT's risk to reward.

DLHC Earnings Per Share

Q3 2023: $0.10Q4 2023: $0.14Q1 2024: $0.21Q2 2024: $0.17Q3 2024: $0.51Q4 2024: $0.44Q1 2025: $0.38Q2 2025: $0.32Q3 2025: $0.10Q4 2025: $-0.07Q1 2026: $-0.30Q2 2026: $-1.48
Q3 2023: $0.10Q4 2023: $0.14Q1 2024: $0.21Q2 2024: $0.17Q3 2024: $0.51Q4 2024: $0.44Q1 2025: $0.38Q2 2025: $0.32Q3 2025: $0.10Q4 2025: $-0.07Q1 2026: $-0.30Q2 2026: $-1.48
QuarterTTM EPSYoY
Q2 2026-$1.48-563%
Q1 2026-$0.30-179%
Q4 2025-$0.07-116%
Q3 2025$0.10-80%
Q2 2025$0.32+88%
Q1 2025$0.38+81%
Q4 2024$0.44+214%
Q3 2024$0.51+410%

DLHC has swung to a loss: it lost $1.48 per share over the past year, after a profit the year before.

VRT Earnings Per Share

Q4 2023: $1.19Q1 2024: $1.05Q2 2024: $1.29Q3 2024: $1.51Q4 2024: $1.28Q1 2025: $1.72Q2 2025: $2.09Q3 2025: $2.65Q4 2025: $3.41Q1 2026: $3.98Q2 2026: $4.42Q3 2026: $5.35Forward: $9.14
Q4 2023: $1.19Q1 2024: $1.05Q2 2024: $1.29Q3 2024: $1.51Q4 2024: $1.28Q1 2025: $1.72Q2 2025: $2.09Q3 2025: $2.65Q4 2025: $3.41Q1 2026: $3.98Q2 2026: $4.42Q3 2026: $5.35Forward: $9.14
QuarterTTM EPSYoY
Forward$9.14+71%
Q3 2026$5.35+102%
Q2 2026$4.42+111%
Q1 2026$3.98+131%
Q4 2025$3.41+166%
Q3 2025$2.65+75%
Q2 2025$2.09+62%
Q1 2025$1.72+64%
Q4 2024$1.28+7.6%

VRT has the edge over DLHC on earnings quality, reporting a profit while its opponent remains loss making.

DLHC Quarterly Revenue

Q3 2023: $101MQ4 2023: $98MQ1 2024: $101MQ2 2024: $101MQ3 2024: $96MQ4 2024: $91MQ1 2025: $89MQ2 2025: $83MQ3 2025: $81MQ4 2025: $69MQ1 2026: $59MQ2 2026: $44M
Q3 2023: $101MQ4 2023: $98MQ1 2024: $101MQ2 2024: $101MQ3 2024: $96MQ4 2024: $91MQ1 2025: $89MQ2 2025: $83MQ3 2025: $81MQ4 2025: $69MQ1 2026: $59MQ2 2026: $44M
QuarterRevenueYoY
Q2 2026$44.2M-47%
Q1 2026$59.3M-34%
Q4 2025$68.9M-24%
Q3 2025$81.2M-16%
Q2 2025$83.3M-17%
Q1 2025$89.2M-12%
Q4 2024$90.8M-7.2%
Q3 2024$96.4M-5%

DLHC's revenue has slid since its 2021 peak: $44M last quarter, down 47% from the same quarter a year ago.

VRT Quarterly Revenue

Q4 2023: $1.9BQ1 2024: $1.6BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.3BQ1 2025: $2BQ2 2025: $2.6BQ3 2025: $2.7BQ4 2025: $2.9BQ1 2026: $2.6BQ2 2026: $3.3BQ3 2026: $4.3B
Q4 2023: $1.9BQ1 2024: $1.6BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.3BQ1 2025: $2BQ2 2025: $2.6BQ3 2025: $2.7BQ4 2025: $2.9BQ1 2026: $2.6BQ2 2026: $3.3BQ3 2026: $4.3B
QuarterRevenueYoY
Q3 2026$4.3B+61%
Q2 2026$3.3B+24%
Q1 2026$2.6B+30%
Q4 2025$2.9B+23%
Q3 2025$2.7B+29%
Q2 2025$2.6B+35%
Q1 2025$2B+24%
Q4 2024$2.3B+26%

VRT has the edge over DLHC on sales, with more consistent year-over-year improvement.

DLHC Free Cash Flow

Q3 2023: $16MQ4 2023: $5MQ1 2024: $5MQ2 2024: $4MQ3 2024: $12MQ4 2024: −$12MQ1 2025: $15MQ2 2025: $9MQ3 2025: $11MQ4 2025: −$5MQ1 2026: $4MQ2 2026: $4M
Q3 2023: $16MQ4 2023: $5MQ1 2024: $5MQ2 2024: $4MQ3 2024: $12MQ4 2024: −$12MQ1 2025: $15MQ2 2025: $9MQ3 2025: $11MQ4 2025: −$5MQ1 2026: $4MQ2 2026: $4M
QuarterFree cash flowYoY
Q2 2026$4.2M-55%
Q1 2026$3.8M-75%
Q4 2025-$4.8M+$7.3M
Q3 2025$10.7M-13%
Q2 2025$9.4M+109%
Q1 2025$15.1M+205%
Q4 2024-$12.1M-347%
Q3 2024$12.2M-24%

DLHC still generates free cash flow, though less than at its 2021 peak: $14M over the past year.

VRT Free Cash Flow

Q4 2023: $308MQ1 2024: $102MQ2 2024: $344MQ3 2024: $342MQ4 2024: $365MQ1 2025: $267MQ2 2025: $278MQ3 2025: $464MQ4 2025: $886MQ1 2026: $654MQ2 2026: $927MQ3 2026: $655M
Q4 2023: $308MQ1 2024: $102MQ2 2024: $344MQ3 2024: $342MQ4 2024: $365MQ1 2025: $267MQ2 2025: $278MQ3 2025: $464MQ4 2025: $886MQ1 2026: $654MQ2 2026: $927MQ3 2026: $655M
QuarterFree cash flowYoY
Q3 2026$654.9M+41%
Q2 2026$926.5M+233%
Q1 2026$654.2M+145%
Q4 2025$885.6M+143%
Q3 2025$463.5M+36%
Q2 2025$277.9M-19%
Q1 2025$266.8M+162%
Q4 2024$364.5M+18%

VRT has the edge over DLHC on cash flow, with more consistent year-over-year improvement.

DLHC Total Shares

Q3 2023: 14MQ4 2023: 15MQ1 2024: 15MQ2 2024: 15MQ3 2024: 14MQ4 2024: 15MQ1 2025: 14MQ2 2025: 14MQ3 2025: 14MQ4 2025: 15MQ1 2026: 14MQ2 2026: 14M
Q3 2023: 14MQ4 2023: 15MQ1 2024: 15MQ2 2024: 15MQ3 2024: 14MQ4 2024: 15MQ1 2025: 14MQ2 2025: 14MQ3 2025: 14MQ4 2025: 15MQ1 2026: 14MQ2 2026: 14M
PeriodChange %Net change
Quarterly0%--
1 year+0.3%+43K shares
3 years+4.3%+593K shares
5 years+6.1%+838K shares
Available history+11%+1.5M shares

DLHC has the edge over VRT on shareholder dilution, with a more favorable share count trend.

VRT Total Shares

Q4 2023: 386MQ1 2024: 379MQ2 2024: 384MQ3 2024: 384MQ4 2024: 386MQ1 2025: 390MQ2 2025: 390MQ3 2025: 391MQ4 2025: 391MQ1 2026: 392MQ2 2026: 393MQ3 2026: 393M
Q4 2023: 386MQ1 2024: 379MQ2 2024: 384MQ3 2024: 384MQ4 2024: 386MQ1 2025: 390MQ2 2025: 390MQ3 2025: 391MQ4 2025: 391MQ1 2026: 392MQ2 2026: 393MQ3 2026: 393M
PeriodChange %Net change
Quarterly0%-64.9K shares
1 year+0.4%+1.8M shares
3 years+1.1%+4.4M shares
5 years+10%+36M shares
Available history+63%+152M shares

VRT has 393M diluted shares, about the same as a year ago.

DLHC Net Leverage

Q3 2023: 5.4xQ4 2023: 4.6xQ1 2024: 4.4xQ2 2024: 4.5xQ3 2024: 3.6xQ4 2024: 4.0xQ1 2025: 3.7xQ2 2025: 3.6xQ3 2025: 3.8xQ4 2025: 4.5xQ1 2026: 5.3xQ2 2026: 7.6x
Q3 2023: 5.4xQ4 2023: 4.6xQ1 2024: 4.4xQ2 2024: 4.5xQ3 2024: 3.6xQ4 2024: 4.0xQ1 2025: 3.7xQ2 2025: 3.6xQ3 2025: 3.8xQ4 2025: 4.5xQ1 2026: 5.3xQ2 2026: 7.6x
QuarterNet LeverageStatus
Q2 20267.6xHigh
Q1 20265.3xHigh
Q4 20254.5xHigh
Q3 20253.8xElevated
Q2 20253.6xElevated
Q1 20253.7xElevated
Q4 20244.0xElevated
Q3 20243.6xElevated

DLHC's net debt is about 7.6 years of its operating earnings (EBITDA), up from 3.6 years a year ago.

VRT Net Leverage

Q4 2023: 1.9xQ1 2024: 2.2xQ2 2024: 1.8xQ3 2024: 1.4xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.7xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.3xQ2 2026: 0.1xQ3 2026: -0.2x
Q4 2023: 1.9xQ1 2024: 2.2xQ2 2024: 1.8xQ3 2024: 1.4xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.7xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.3xQ2 2026: 0.1xQ3 2026: -0.2x
QuarterNet LeverageStatus
Q3 2026-0.2xNet Cash
Q2 20260.1xVery low
Q1 20260.3xVery low
Q4 20250.6xVery low
Q3 20250.8xVery low
Q2 20250.7xVery low
Q1 20250.8xVery low
Q4 20241.0xHealthy

VRT has the edge over DLHC on leverage, with a lower net debt burden relative to earnings.

DLHC Weekly Momentum

MetricValueStatus
RSI31.0Neutral
Stochastic11.3Oversold

DLHC's weekly RSI is 31 (neutral) and its Stochastic is 11 (oversold).

VRT Weekly Momentum

MetricValueStatus
RSI43.0Neutral
Stochastic26.4Neutral

VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).

DLHC PE vs Industrials Sector

MetricDLHCSector medianRelative
PEN/A24x—

DLHC has no meaningful PE right now: it lost money over the past year.

VRT PE vs Industrials Sector

MetricVRTSector medianRelative
PE39x24x63% above
PE %35855 pts below

VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.

DLHC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.807.9% below
20 week MA$4.3219% below
50 week MA$5.1732% below
100 week MA$5.3935% below
200 week MA$8.5359% below

DLHC is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.

VRT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$221.85.5% below
20 week MA$254.418% below
50 week MA$253.917% below
100 week MA$189.111% above
200 week MA$123.570% above

VRT has the edge over DLHC on trend strength, trading above more of its moving averages.

DLHC Yearly ROI

YearStart priceEnd priceROI
2020$4.12$9.15+122%
2021$9.15$18.0+97%
2022$18.0$12.5-30%
2023$12.5$15.8+26%
2024$15.8$7.63-52%
2025$7.63$5.65-26%
2026 YTD$5.65$3.50-38%

DLHC's yearly returns have swung widely, from +122% in 2020 to −52% in 2024. It's down 38% so far in 2026.

VRT Yearly ROI

YearStart priceEnd priceROI
2020$10.9$18.9+73%
2021$18.9$24.9+31%
2022$24.9$12.8-48%
2023$12.8$48.0+275%
2024$48.0$115.1+140%
2025$115.1$167.6+46%
2026 YTD$167.6$209.6+25%

VRT has the edge over DLHC on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key